$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
恩格列净国内上市没呢?
2025-10-19 11:44:20
Check Details
恩格列净推荐的用量多少呢?
2025-10-19 11:44:20
Check Details
恩格列净服用说明
2025-10-19 11:44:20
Check Details
恩格列净 使用说明
2025-10-19 11:44:20
Check Details
恩格列净 说明书
2025-10-19 11:44:20
Check Details
恩格列净药品说明书
2025-10-19 11:44:20
Check Details
恩格列净上市的时间
2025-10-19 11:44:20
Check Details
恩格列净要怎么使用?
2025-10-19 11:44:20
Check Details
恩格列净常见副作用
2025-10-19 11:44:20
Check Details
恩格列净的疗效好吗?
2025-10-19 11:44:20
Check Details
欧唐静服用说明
2025-10-19 11:44:20
Check Details
欧唐静需要注意什么事项呢?
2025-10-19 11:44:20
Check Details
1
2
...
5357
5358
5359
5360
5361
5362
5363
...
10218
10219
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Common Adverse Reactions and Clinical Safety Management of Gilteritinib (Xospata)
2
Lemborexant: Mechanism of Action and Clinical Profile of a Dual Orexin Receptor Antagonist
3
Adverse Reaction Profile and Clinical Safety Management of Idelalisib
4
Avutometinib Plus Defactinib: A Precision Therapy for KRAS-Mutant Recurrent Low-Grade Serous Ovarian Cancer
5
Mechanism and Clinical Value of Pemafibrate in Triglyceride Lowering
6
Phase 1 Study Progress of Ceralasertib in Combination with Durvalumab for Advanced NSCLC and HNSCC
7
Pegloticase (Krystexxa) Complete Medication Guide
8
Vemurafenib (Zelboraf) Complete Medication Guide
9
Guide to Long-Term Ramipril Use: Safety and Renal Function Management
10
Mechanism and Clinical Positioning of Leflunomide: A Comprehensive Guide to csDMARDs
11
Comprehensive Clinical Guide to Risankizumab (Skyrizi): Dosing, Contraindications, and Safety
12
Management Strategies and Long-Term Outcomes Following 6 Months of Pegloticase (Krystexxa) Therapy